Navigate to
-
research 10 research posters presented by Prime at AMCP Nexus 2024 Studies include Prime’s GLP-1 obesity research, health equity, and real world case studies Evaluating the 10-Year Impact of an...
-
Weight loss Support and empower weight loss in a healthy, manageable and sustainable way with customized paths for each member. Medication management Improve drug adherence or reduce the number of...
-
Flexible, cost-effective, strategic partnership Specialty drugs have changed the pharmacy landscape over the past decade and now represent more than half of total drug spend. Having a strong...
-
Care Specialists program Help your members on high-cost clinical drugs Insert Link Help members and their prescribers make better decisions about medicines through this clinical intelligence hub...
-
*select countries included adolescents 12 years and older weighing 30 kg or more Autoimmune/immunology Proposed indications Treatment of Steroid-Refractory Acute Graft vs. Host Disease (SR-aGVHD) –...
-
Biobetters are just a nickname; they’re based on existing biologics but with a few key differences
PA Sub-Categories: Specialty drugs Prime Article: Perspectives -
Oncology Insights Oncology Case Management and Navigation: How do they differ? Caring for and treating a patient with cancer is complex. Many patients struggle to coordinate therapy, manage...
-
50M Footnotes As many as 50M people in the United States have an autoimmune disease, making it the third most prevalent disease category, surpassed only by cancer and heart disease.2 Unlock...
-
High Cost Therapy Profile Eyebrow High-Cost Therapy Profile: February Detailed information about Marnetegragene autotemcel Intravenous (IV) Gene Therapy/Immunology Marnetegragene autotemcel...
-
Medication Nonadherence Social Determinants of Health Risk Score: Development and Use 2024 AMCP Annual Posters Real-World First Year Cost-Effectiveness Assessment of Glucagon-Like Peptide-1...
-
Insert Link Medical Formulary Strategy ensures the most appropriate and clinically effective medical benefit drugs are evaluated with product-preferencing strategies, for all lines of business....
-
For the first time, Prime Therapeutics hosted the AMCP Nexus specialty keynote, addressing trends in cell and gene therapy and rare disease and immunology categories
PA Sub-Categories: Specialty drugs Prime Article: Perspectives -
May 22, 2025 – mepolizumab (Nucala) GlaxoSmithKline; an IL-5 antagonist monoclonal antibody New indication: add-on maintenance treatment of adults with inadequately controlled chronic obstructive...
-
Clinical deep dive Disease state overview WAS is a rare, X-linked, genetic disorder characterized by thrombocytopenia, eczema, immunodeficiency, and increased risk of autoimmunity and...
-
All brand names are property of their respective owners. References Kim SY, Park HS, Chiang AC. Small Cell Lung Cancer: A Review. JAMA. 2025;333(21):1906-1917. doi:10.1001/jama.2025.0560...
-
Last year, Oncology Insights brought you the most talked about topics in 2024. As we enter this new year, let us review these impactful and potentially practicing changing subjects that are likely...
-
Methodological Framework for Propensity Adjusted Benchmarks for Pharmacy Key Performance Indicators The purpose of the study was to create a methodological framework for using propensity score...
-
Marquee event showcased new Prime, our energy, ambition and transformative journey
PA Sub-Categories: Specialty drugs Prime Article: Perspectives -
Drs. Tracey Garcia and Amy Pappas, board-certified neurologists, reviewed migraine risk factors and treatments in a recent webinar moderated by Dr. Marci Chodroff, vice president of medical affairs
Prime Article: Stories -
Empowering client, providers and members 2024: Using real-time pricing, Pharmacy Match drives affordability for plan sponsors while offering access to the most competitive pharmacy for each member....
-
Whitepaper Tab 1 Myth 1 Myth 2 Myth 3 Myth 4 Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed nec ornare mi. Praesent ultrices ipsum eget est rutrum, eget congue orci molestie. Sed diam...
-
Clinical deep dive Disease state overview Myelodysplastic syndromes (MDS) are classified as disorders in which there are abnormal (dysplastic) hematopoietic stem cells in the bone marrow, leading...
-
Jessica Johnson, clinical consultant at Prime Therapeutics, shares how the Special Investigations Unit (SIU) helps prevent fraud, waste and abuse (FWA) in health care
Prime Article: Perspectives -
Prime is pleased to present the seventh edition of the Employer Market Insights Report. Within this one-of-a-kind publication, you’ll find critical pharmacy trend insights that will help you make...
-
Clinical deep dive Disease state overview MacTel type 2 is a rare neurodegenerative disease that affects the macula, which processes central and color vision. It is a bilateral asymmetric...
-
Publications High Cost Therapy Profile: October 2024 Eladocagene Exuparvovec October 15, 2024 References PTC Therapeutics announces FDA acceptance and Priority Review of the BLA for UpstazaTM. PTC...
-
Event features discussions about health care industry trends, best practices and innovations
PA Sub-Categories: Specialty drugs Prime Article: Stories -
Home Our solutions Modern technology MyRxInsights Our advanced analytics platform helps boost your clinical impact and drive down costs by delivering descriptive, diagnostic, predictive and...
-
When you fill your specialty prescription, we automatically enroll you in our Care Specialists program. Our care specialists are pharmacists and nurses who are specially trained in your condition....
-
Eyebrow High-Cost Therapy Profile: August 2024 Detailed information about intravenous (IV) linvoseltamab Oncology Linvoseltamab, intravenous (IV) Regeneron Pharmaceuticals Proposed indications...
-
NMPI: National Medicaid Pooling Initiative We negotiate the best price available from the pharmaceutical industry on behalf of our participating clients. View resources Services we offer Our...
-
Identifying the associated medical cost savings with improving medication adherence study earns organization’s platinum award.
PA Sub-Categories: GLP-1 Specialty drugs Prime Article: Press Releases -
Research awards AMCP Silver Award – Controlled Substances Triple Threat Overlapping Days: Relationship with Healthcare Utilization and Costs Academy of Managed Care Pharmacy: Annual Meeting AMCP...
-
Special Investigations Unit helps promote safety to prevent fraud, waste and abuse schemes
Prime Article: Perspectives -
Stories, perspectives and news coverage of Prime Therapeutics/Magellan Rx from AMCP 2024
Prime Article: Stories -
In this episode, our experts discuss Prime’s four primary tenets of practice for chronic weight management.
Prime Article: Stories -
Senior Account Manager - Remote Investment Accountant, Principal - Remote Job description: The Senior Financial Application Analyst is responsible for the administration of the Hyperion application...
-
The autologous, engineered cell therapy by Abeona, prademagene zamikeracel, has been resubmitted to the FDA for the treatment of recessive dystrophic epidermolysis bullosa (RDEB). This is the...
-
Join us and help reimagine pharmacy benefit management to provide the same care you would want for your loved ones. Check out our Careers page to see additional job listings, benefits and more....
-
Event features Prime experts
Prime Article: Events -
Clinical Solutions Vice President (Remote) Job description: The Medicare Part D pharmacy programs manager manages the coordination of benefits in the pharmacy program with Medicare Part D plans,...
-
Formulary design recommendations help create competition to drive savings, provide optionality to meet unique client needs.
PA Sub-Categories: Specialty drugs Prime Article: Press Releases -
If you think about the rise of specialty drugs as a Category 5 hurricane, and the growth of gene therapies as an undersea earthquake, you can see the rising tsunami of drug spend looking to sweep...
PA Sub-Categories: Products Specialty drugs Prime Article: Stories -
In this special episode of the Pharmacy Friends podcast, “Live at Specialty Summit ’24 – Connect. Elevate. Transform.,” we are on the road in New York City at our 21st annual Specialty Summit. More...
PA Sub-Categories: Specialty drugs Prime Article: Stories -
The SIU promotes safety to prevent fraud, waste and abuse schemes
Prime Article: Perspectives -
Clinical Solutions VP (Remote) Looking for your next career move and want to help Prime Therapeutics (Prime) put more care in health care? Check out the Prime Careers Spotlight, a monthly roundup...
-
Recent webinar featuring Prime Therapeutics experts shares some of the latest breakthrough therapies — including ADCs, BiTes and CAR-T treatments — and regulatory changes and market shifts that are...
PA Sub-Categories: Specialty drugs Prime Article: Stories -
Dinesh Kandanchatha joined the organization July 1.
Prime Article: Press Releases -
Parikh, director of medical pharmacy strategy at Prime/MRx, shares the latest on interchangeable biosimilars
Prime Article: Stories -
Prime Therapeutics/Magellan Rx Management's signature event featured the hottest topics in specialty drug management and more
PA Sub-Categories: Specialty drugs Prime Article: Stories -
Prime Therapeutics offers first-of-its-kind digital utilization management solution that pairs biomarker testing with targeted therapy drug selection
PA Sub-Categories: Products Specialty drugs Prime Article: Stories -
New report highlights value-based contract solution and analysis of top 10 drug classes impacting Medicaid pharmacy net trend
PA Sub-Categories: Products Specialty drugs Prime Article: Stories -
As the efficacy and cost of these therapies become clear, so is the need for thoughtful managed care strategies, according to Prime Therapeutics thought leaders
PA Sub-Categories: Specialty drugs Prime Article: Stories -
Insights from Academy of Managed Care Pharmacy (AMCP) Nexus 2023
PA Sub-Categories: Specialty drugs Prime Article: Stories -
Prime works to simplify medication management and support patients with migraine, making migraine treatment less of a pain point
Prime Article: Stories -
Cover image for Drug Approvals Monthly Update: September 2024 This monthly update of United States (U.S.) Food and Drug Administration (FDA) approvals provides a review of newly approved specialty...
Prime Article: Research & Publications PA Research & Publications: Drug Approvals -
Cover image for Drug Approvals Monthly Update: August 2024 This monthly update of United States (U.S.) Food and Drug Administration (FDA) approvals provides a review of newly approved specialty...
Prime Article: Research & Publications PA Research & Publications: Drug Approvals -
Lead author David Eckwright shares more about the study “Real-World Extended Dosing Assessment for Eye(s) new to Faricimab-svoa Therapy.”
PA Sub-Categories: Specialty drugs Prime Article: Perspectives -
Cover AMCP Prime Therapeutics /amcp-nexus-2024-research-posters 10 research posters presented by Prime at AMCP Nexus 2024 covers topics like GLP-1 obesity research, health equity initiatives, and...
Prime Article: Research & Publications PA Research & Publications: Research posters -
Cover image for 8 research posters presented by Prime at the 2024 AMCP Annual Meeting 2024 AMCP Annual Meeting Prime Therapeutics /2024-amcp-annual-meeting-research-posters 8 research posters...
Prime Article: Research & Publications PA Research & Publications: Research posters